ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,027,000 | +134.8% | 54,093 | +50.5% | 0.13% | +238.5% |
| Q3 2021 | $2,141,000 | +85.0% | 35,949 | +111.9% | 0.04% | +85.7% |
| Q2 2021 | $1,157,000 | +108.5% | 16,968 | +112.2% | 0.02% | +110.0% |
| Q1 2021 | $555,000 | -82.0% | 7,998 | -80.1% | 0.01% | -82.1% |
| Q4 2020 | $3,091,000 | – | 40,227 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |